Clinical TrialsEnrollment in the Phase 1 study of WVE-007 for obesity has been completed, showing advancement in their clinical trials.
Financial StabilityEnd of total cash will support a runway into 2027, indicating financial stability.
Research ProgressWVE has narrowed the timing for expected data updates in their alpha-1-antitrypsin deficiency program, indicating progress in their research.